These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 31381523)

  • 1. The Prospective Huntington At-Risk Observational Study (PHAROS): The Emotional Well-Being, Safety and Feasibility of Long-Term Research Participation.
    Kayson E; Eberly S; Anderson KE; Marder K; Shoulson I; Oakes D; Young AB; Biglan K; Hersch S;
    J Huntingtons Dis; 2019; 8(4):435-441. PubMed ID: 31381523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.
    ; Biglan KM; Shoulson I; Kieburtz K; Oakes D; Kayson E; Shinaman MA; Zhao H; Romer M; Young A; Hersch S; Penney J; Marder K; Paulsen J; Quaid K; Siemers E; Tanner C; Mallonee W; Suter G; Dubinsky R; Gray C; Nance M; Bundlie S; Radtke D; Kostyk S; Baic C; Caress J; Walker F; Hunt V; O'Neill C; Chouinard S; Factor S; Greenamyre T; Wood-Siverio C; Corey-Bloom J; Song D; Peavy G; Moskowitz C; Wesson M; Samii A; Bird T; Lipe H; Blindauer K; Marshall F; Zimmerman C; Goldstein J; Rosas D; Novak P; Caviness J; Adler C; Duffy A; Wheelock V; Tempkin T; Richman D; Seeberger L; Albin R; Chou KL; Racette B; Perlmutter JS; Perlman S; Bordelon Y; Martin W; Wieler M; Leavitt B; Raymond L; Decolongon J; Clarke L; Jankovic J; Hunter C; Hauser RA; Sanchez-Ramos J; Furtado S; Suchowersky O; Klimek ML; Guttman M; Sethna R; Feigin A; Cox M; Shannon B; Percy A; Dure L; Harrison M; Johnson W; Higgins D; Molho E; Nickerson C; Evans S; Hobson D; Singer C; Galvez-Jimenez N; Shannon K; Comella C; Ross C; Saint-Hilaire MH; Testa C; Rosenblatt A; Hogarth P; Weiner W; Como P; Kumar R; Cotto C; Stout J; Brocht A; Watts A; Eberly S; Weaver C; Foroud T; Gusella J; MacDonald M; Myers R; Fahn S; Shults C
    JAMA Neurol; 2016 Jan; 73(1):102-10. PubMed ID: 26569098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors related to genetic testing in adults at risk for Huntington disease: the prospective Huntington at-risk observational study (PHAROS).
    Quaid KA; Eberly SW; Kayson-Rubin E; Oakes D; Shoulson I;
    Clin Genet; 2017 Jun; 91(6):824-831. PubMed ID: 27740685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenotype-genotype discrepancies in the prospective Huntington at-risk observational study.
    Shoulson I; Eberly S; Oakes D; Kayson E; Young AB;
    Ann Clin Transl Neurol; 2019 Jun; 6(6):1046-1052. PubMed ID: 31211168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary intake in adults at risk for Huntington disease: analysis of PHAROS research participants.
    Marder K; Zhao H; Eberly S; Tanner CM; Oakes D; Shoulson I;
    Neurology; 2009 Aug; 73(5):385-92. PubMed ID: 19652143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the correlates of intermediate CAG repeats in Huntington disease.
    Ha AD; Jankovic J
    Postgrad Med; 2011 Sep; 123(5):116-21. PubMed ID: 21904093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suicidality in Huntington's Disease: A Qualitative Study on Coping Styles and Support Strategies.
    Hubers AA; Hamming A; Giltay EJ; von Faber M; Roos RA; van der Mast RC; van Duijn E
    J Huntingtons Dis; 2016 May; 5(2):185-98. PubMed ID: 27258585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychiatric and cognitive difficulties as indicators of juvenile huntington disease onset in 29 patients.
    Ribaï P; Nguyen K; Hahn-Barma V; Gourfinkel-An I; Vidailhet M; Legout A; Dodé C; Brice A; Dürr A
    Arch Neurol; 2007 Jun; 64(6):813-9. PubMed ID: 17562929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychological functioning before predictive testing for Huntington's disease: the role of the parental disease, risk perception, and subjective proximity of the disease.
    Decruyenaere M; Evers-Kiebooms G; Boogaerts A; Cassiman JJ; Cloostermans T; Demyttenaere K; Dom R; Fryns JP
    J Med Genet; 1999 Dec; 36(12):897-905. PubMed ID: 10593997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Living at risk: concealing risk and preserving hope in Huntington disease.
    Quaid KA; Sims SL; Swenson MM; Harrison JM; Moskowitz C; Stepanov N; Suter GW; Westphal BJ
    J Genet Couns; 2008 Feb; 17(1):117-28. PubMed ID: 17943424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. To know or not to know: a review of behaviour and suicidal ideation in preclinical Huntington's disease.
    Robins Wahlin TB
    Patient Educ Couns; 2007 Mar; 65(3):279-87. PubMed ID: 17000074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Presymptomatic testing for Huntington's disease.
    Bird SJ
    JAMA; 1985 Jun; 253(22):3286-91. PubMed ID: 3158756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The choice not to undergo genetic testing for Huntington disease: Results from the PHAROS study.
    Anderson KE; Eberly S; Marder KS; Oakes D; Kayson E; Young A; Shoulson I;
    Clin Genet; 2019 Jul; 96(1):28-34. PubMed ID: 31093973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emotional and functional impact of DNA testing on patients with symptoms of Huntington's disease.
    Jankovic J; Beach J; Ashizawa T
    J Med Genet; 1995 Jul; 32(7):516-8. PubMed ID: 7562962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. At risk for Huntington disease: The PHAROS (Prospective Huntington At Risk Observational Study) cohort enrolled.
    Huntington Study Group PHAROS Investigators
    Arch Neurol; 2006 Jul; 63(7):991-6. PubMed ID: 16831969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic testing and mental health: the model of Huntington disease.
    Williams JK; Schutte DL
    Online J Issues Nurs; 2000; 5(3):3. PubMed ID: 11380269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ripples from a stone skipping across the lake: a narrative approach to the meaning of Huntington's disease.
    Schwartz RR
    J Neurosci Nurs; 2010 Jun; 42(3):157-68. PubMed ID: 20550076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of molecular testing in Huntington's disease.
    Wang V; Yeh TP; Chen CM; Yan SH; Soong BW
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Sep; 62(9):586-90. PubMed ID: 10502848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease.
    Almqvist EW; Bloch M; Brinkman R; Craufurd D; Hayden MR
    Am J Hum Genet; 1999 May; 64(5):1293-304. PubMed ID: 10205260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of depression in prodromal Huntington disease in the neurobiological predictors of HD (PREDICT-HD) study.
    Epping EA; Mills JA; Beglinger LJ; Fiedorowicz JG; Craufurd D; Smith MM; Groves M; Bijanki KR; Downing N; Williams JK; Long JD; Paulsen JS;
    J Psychiatr Res; 2013 Oct; 47(10):1423-31. PubMed ID: 23790259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.